Oral Tobacco Pouch 'ZYN by IQOS' Expands Sales in Tokyo from Monday, May 11, 2026

Philip Morris Japan Limited (Headquarters: Chiyoda-ku, Tokyo; President: Shelley Goh; hereinafter 'PMJ') will sequentially expand sales of the oral tobacco pouch 'ZYN by IQOS', which had been pre-released in limited areas since July 2025, starting Monday, May 11, 2026. The new sales locations will include IQOS shops in Tokyo (select Yamada Denki and Bic Camera stores, etc.) *1, IQOS corners in Tokyo (select Don Quijote affiliated stores, etc.) *1, and Lawson stores in Tokyo *1 *2.

'ZYN' contains a powder of finely chopped high-quality tobacco leaves, along with components extracted from tobacco leaves.

Aiming for a 'Smoke-Free Future', PMJ will continue striving to provide products and services that satisfy adult smokers aged 20 and over.

*1 Delivery dates and sales start dates vary by store.
*2 Only 6 out of all 8 products (Cool Mint Low/Medium, Spearmint Low/Medium, Peach Low/Medium) will be sold.

'ZYN by IQOS' Product Information

The 'ZYN' products expanding sales in Tokyo are as follows:

Product Name:
ZYN by IQOS
- Cool Mint (Low/Medium)
- Spearmint (Low/Medium)
- Apple Mint (Low/Medium)
- Peach (Low/Medium)

Product Features:
- 'ZYN' is an oral tobacco pouch used by placing it under the upper lip.
- It requires no burning or heating, offering a hands-free, rich flavor experience for approximately 30 minutes.
- It is available in two strengths: the 'ZYN Low' series for a moderate stimulation, and the 'ZYN Medium' series for a stronger sensation.
*For first-time users, we recommend starting with the Low series. Depending on the individual, it may take some time to get used to the new sensation of oral tobacco pouches.

Packaging / Price:
12 pouches / 500 yen (tax included)

Launch Date / Area:
Sales will sequentially expand starting Monday, May 11, 2026.

1) Existing sales locations:
- ZYN Online Store
- IQOS Store (Ginza)
- Select tobacco retailers in Shibuya-ku, Tokyo
- Duty-free shops (select stores in Narita International Airport, Tokyo International Airport [Haneda], and Kansai International Airport)

2) Newly expanded sales locations:
- IQOS shops in Tokyo (select Yamada Denki and Bic Camera stores) *1
- IQOS corners in Tokyo (select Don Quijote and Viva Home affiliated stores) *1
- Lawson stores in Tokyo *1 *2

*1 Delivery dates and sales start dates vary by store.
*2 Only 6 out of all 8 products (Cool Mint Low/Medium, Spearmint Low/Medium, Peach Low/Medium) will be sold.

PMI's Corporate Vision: Global Leader in a 'Smoke-Free Future'
Philip Morris International ('PMI') is a leading international consumer goods company actively engaged in evolving its portfolio long-term, including non-combustible and non-nicotine products, with the goal of realizing a 'smoke-free future.' Its current product portfolio consists primarily of combustible cigarettes and smoke-free products. As of December 31, 2025, PMI's smoke-free products are available for sale in major cities or nationwide across 106 markets globally. It is estimated that approximately 43.5 million adult smokers (aged 20 and over in Japan) use PMI's smoke-free products worldwide. The business related to smoke-free products accounts for approximately 41.5% of PMI's full-year net revenues for 2025.

Since 2008, PMI has invested 16 billion USD to develop, scientifically substantiate, and commercialize innovative smoke-free products for adult smokers who would otherwise continue to smoke, aiming to completely phase out the sale of cigarettes. This includes building world-class scientific assessment capabilities, particularly in the areas of preclinical systems toxicology, clinical and behavioral research, and post-market surveillance. Following rigorous science-based reviews, the U.S. Food and Drug Administration (FDA) authorized the marketing of Swedish Match's 'General snus' and oral nicotine pouch 'ZYN', as well as certain PMI IQOS devices and tobacco sticks. These were the first authorizations in their respective categories. Additionally, certain IQOS devices and tobacco sticks, as well as General snus, were authorized by the FDA as the first Modified Risk Tobacco Products (MRTP).